AAAAAA
Results:
1-13
|
Results: 13
Authors:
GREENSPAN SL
PARKER RA
FERGUSON L
ROSEN HN
MAITLANDRAMSEY L
KARPF DB
Citation: Sl. Greenspan et al., EARLY CHANGES IN BIOCHEMICAL MARKERS OF BONE TURNOVER PREDICT THE LONG-TERM RESPONSE TO ALENDRONATE THERAPY IN REPRESENTATIVE ELDERLY WOMEN- A RANDOMIZED CLINICAL-TRIAL, Journal of bone and mineral research, 13(9), 1998, pp. 1431-1438
Authors:
KARPF DB
Citation: Db. Karpf, INJURY PREVENTION, The New England journal of medicine, 338(2), 1998, pp. 133-133
Authors:
GREENSPAN SL
PARKER RA
KARPF DB
Citation: Sl. Greenspan et al., SHORT-TERM DECREASES IN BIOCHEMICAL MARKERS PREDICT LONG-TERM RESPONSE TO ALENDRONATE THERAPY IN REPRESENTATIVE ELDERLY WOMEN, Journal of bone and mineral research, 12, 1997, pp. 275-275
Authors:
DAIFOTIS AG
KARPF DB
Citation: Ag. Daifotis et Db. Karpf, SUMMARY OF SAFETY PROFILE AND FUTURE-RESEARCH WITH ALENDRONATE, British journal of rheumatology, 36, 1997, pp. 20-23
Authors:
SHAPIRO DR
SANTORA AC
KARPF DB
Citation: Dr. Shapiro et al., METAANALYSIS OF PREVENTION OF NONVERTEBRAL FRACTURES BY ALENDRONATE -REPLY, JAMA, the journal of the American Medical Association, 278(8), 1997, pp. 631-632
Authors:
KARPF DB
SHAPIRO DR
SEEMAN E
ENSRUD KE
JOHNSTON CC
ADAMI S
HARRIS ST
SANTORA AC
HIRSCH LJ
OPPENHEIMER L
THOMPSON D
Citation: Db. Karpf et al., PREVENTION OF NONVERTEBRAL FRACTURES BY ALENDRONATE - A METAANALYSIS, JAMA, the journal of the American Medical Association, 277(14), 1997, pp. 1159-1164
Authors:
ENSRUD KE
BLACK DM
PALERMO L
BAUER DC
BARRETTCONNOR E
QUANDT SA
THOMPSON DE
KARPF DB
Citation: Ke. Ensrud et al., TREATMENT WITH ALENDRONATE PREVENTS FRACTURES IN WOMEN AT HIGHEST RISK - RESULTS FROM THE FRACTURE INTERVENTION TRIAL, Archives of internal medicine, 157(22), 1997, pp. 2617-2624
Authors:
BLACK DM
CUMMINGS SR
KARPF DB
CAULEY JA
THOMPSON DE
NEVITT MC
BAUER DC
GENANT HK
HASKELL WL
MARCUS R
OTT SM
TORNER JC
QUANDT SA
REISS TF
ENSRUD KE
Citation: Dm. Black et al., RANDOMIZED TRIAL OF EFFECT OF ALENDRONATE ON RISK OF FRACTURE IN WOMEN WITH EXISTING VERTEBRAL FRACTURES, Lancet, 348(9041), 1996, pp. 1535-1541
Authors:
LIBERMAN U
KARPF DB
CAPIZZI T
Citation: U. Liberman et al., ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS - REPLY, The New England journal of medicine, 334(11), 1996, pp. 734-735
Authors:
SHAPIRO DR
THOMPSON DE
KARPF DB
SANTORA AC
LOMBARDI A
HIRSCH LJ
SEEMAN E
BELL N
ORTOLANI S
HARRIS ST
ENSRUD K
Citation: Dr. Shapiro et al., NONVERTEBRAL FRACTURE INCIDENCE IN PATIENTS TREATED WITH ALENDRONATE, Journal of bone and mineral research, 10, 1995, pp. 176-176
Authors:
LIBERMAN UA
WEISS SR
BROLL J
MINNE HW
QUAN H
BELL NH
RODRIGUEZPORTALES J
DOWNS RW
DEQUEKER J
FAVUS M
SEEMAN E
RECKER RR
CAPIZZI T
SANTORA AC
LOMBARDI A
SHAH RV
HIRSCH LJ
KARPF DB
Citation: Ua. Liberman et al., EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS, The New England journal of medicine, 333(22), 1995, pp. 1437-1443
Authors:
GARNERO P
SHIH WCJ
GINEYTS E
KARPF DB
DELMAS PD
Citation: P. Garnero et al., COMPARISON OF NEW BIOCHEMICAL MARKERS OF BONE TURNOVER IN LATE POSTMENOPAUSAL OSTEOPOROTIC WOMEN IN RESPONSE TO ALENDRONATE TREATMENT, The Journal of clinical endocrinology and metabolism, 79(6), 1994, pp. 1693-1700
Authors:
BLACK DM
REISS TR
KARPF DB
CUMMINGS SR
Citation: Dm. Black et al., FRACTURE INTERVENTION TRIAL - DESIGN AND INTERIM RECRUITMENT RESULTS, Journal of bone and mineral research, 8, 1993, pp. 190000259-190000259
Risultati:
1-13
|